Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

New impotence Rx now available in U.S.

Jan. 16, 1997

Approval sought for Androtest-SL

Jan. 16, 1997

Pharmacia & Upjohn's Estring now available on U.S. market

Jan. 16, 1997

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Jan. 16, 1997

Ion exercises option to license sickle cell anemia Rx

Jan. 14, 1997

Canadian launch for antiobesity drug

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Positive phase III results reported for SCF

Jan. 13, 1997

Millennium/Roche obesity collaboration results in another significant discovery

Jan. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...